Literature DB >> 11176071

Myofibrosarcoma: a clinicopathologic study.

E Montgomery1, J R Goldblum, C Fisher.   

Abstract

The concept of soft tissue sarcomas composed predominantly of myofibroblasts has been controversial. We examined a series of such lesions of low- and intermediate-grade malignancy to further define their clinical and pathologic features. Histologic appearances of four cases diagnosed as myofibrosarcoma by electron microscopy were reviewed. Eleven additional cases with similar morphology were then identified from 249 tumors originally indexed as fibrosarcoma. Electron microscopy was performed on five of these, and immunohistochemistry was carried out on all cases for which material was available. There were 11 men and 4 women aged 33 to 73 years (median, 54 yrs; mean, 53 yrs). Lesions mainly involved the head and neck, extremities, and trunk and ranged in size from 1.5 to 12 cm. The tumors were composed of bland or pleomorphic stellate to spindled cells with eosinophilic cytoplasm and tapered nuclei in a collagenous stroma; 10 were grade 1 and five were grade 2. All sarcomas displayed fascicular or storiform patterns, and some of the grade 1 lesions superficially mimicked nodular fasciitis. Electron microscopy of nine cases showed myofibroblastic differentiation, and immunohistochemistry showed smooth muscle actin in 13 of 15 cases, muscle-specific actin in 7 of 9, desmin in 6 of 14, and cytokeratin in 0 of 11. Four of nine grade 1 and three of four grade 2 tumors recurred (one twice), and one grade 2 tumor metastasized to the lungs. Myofibrosarcomas are indolent low-grade or occasionally aggressive intermediate-grade sarcomas which can be recognized by light microscopy. Their clinical importance lies in the resemblance, particularly of low-grade examples, to reactive or pseudosarcomatous conditions.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11176071     DOI: 10.1097/00000478-200102000-00010

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  29 in total

1.  Multicentric myofibroblastic sarcoma.

Authors:  Mihir Dilip Wechalekar; Oliver Ayres; Gelareh Farshid; Mark Clayer; Leslie G Cleland
Journal:  BMJ Case Rep       Date:  2014-11-03

2.  Breast sarcoma showing myofibroblastic differentiation.

Authors:  Ksenija Lucin; Elvira Mustać; Nives Jonjić
Journal:  Virchows Arch       Date:  2003-07-03       Impact factor: 4.064

3.  Unusual sarcomatoid neoplasm of the lung suggesting a myofibrosarcoma.

Authors:  Lars Morawietz; Cornelius Kuhnen; Detlef Katenkamp; Philipp Le Coutre; Axel Ladhoff; Iver Petersen
Journal:  Virchows Arch       Date:  2005-09-13       Impact factor: 4.064

4.  Long-term disease-free survival after radical local excision of low-grade myofibroblastic sarcoma of the vulva.

Authors:  Yumi Murakami; Hiroshi Tsubamoto; Hiroyuki Hao; Soh Nishimoto; Hiroaki Shibahara
Journal:  Gynecol Oncol Case Rep       Date:  2013-04-06

5.  Myofibroblastic sarcoma in liver: a case report.

Authors:  Xiaoping Yi; Desheng Xiao; Xueying Long
Journal:  Int J Clin Exp Pathol       Date:  2015-01-01

6.  A rare case of low-grade myofibroblastic sarcoma of the femur in a 38-year-old woman: a case report.

Authors:  Raman Arora; Ruchika Gupta; Alok Sharma; Amit K Dinda
Journal:  J Med Case Rep       Date:  2010-04-28

7.  Low-grade myofibroblastic sarcoma of the distal femur.

Authors:  Tsuyoshi Saito; Hiroyuki Mitomi; Aiko Kurisaki; Tomoaki Torigoe; Tatsuya Takagi; Yoshiyuki Suehara; Taketo Okubo; Kazuo Kaneko; Takashi Yao
Journal:  Int J Surg Case Rep       Date:  2012-11-23

8.  Collagenous myofibroblastic tumor of the mandible: case report of a unique locally aggressive neoplasm.

Authors:  Jason W Nash; Amy C Hessel; Nadarajah Vigneswaran; Adel K El-Naggar
Journal:  Head Neck Pathol       Date:  2009-12-10

Review 9.  [Myofibroblastic sarcoma of the larynx : a case report and review].

Authors:  S Schröder; B Stengel; A Radtke; D Kleemann
Journal:  HNO       Date:  2009-12       Impact factor: 1.284

Review 10.  Myofibrosarcoma.

Authors:  Cyril Fisher
Journal:  Virchows Arch       Date:  2004-06-02       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.